| Literature DB >> 34996417 |
Femke Nawijn1, Mark van Heijl2,3, Jort Keizer4, Paul J van Koperen5, Falco Hietbrink2.
Abstract
BACKGROUND: The primary aim of this study was to identify if there is an association between the operative time of the initial debridement for necrotizing soft tissue infections (NSTIs) and the mortality corrected for disease severity.Entities:
Keywords: Damage control; Mortality; Necrotizing fasciitis; Necrotizing soft tissue infections; Operative time; Severe necrotizing soft tissue infection
Mesh:
Year: 2022 PMID: 34996417 PMCID: PMC8742342 DOI: 10.1186/s12893-021-01456-0
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Fig. 1Inclusion flowchart of necrotizing soft tissue infections patients undergoing surgery
Patient characteristics of necrotizing soft tissue infection patients undergoing surgery
| Age in years, mean ± SD | 56 ± 16 |
| Male sex, n (%) | 108 (68) |
| ASA classification | |
| I | 33 (21) |
| II | 65 (41) |
| III | 52 (32) |
| IV | 10 (6) |
| Location of NSTI, n (%) | |
| Head/neck | 8 (5) |
| Trunk | 16 (10) |
| Perineum | 44 (27) |
| Upper extremity | 19 (12) |
| Lower extremity | 72 (45) |
| Multiple body areas involved | 1 (1) |
| Estimated TBSA affected in %a, median (IQR) | 3 (2–6) |
| 0–5% | 111 (70) |
| 6–10% | 36 (23) |
| 11–15% | 7 (4) |
| > 15% | 4 (3) |
| Cultured micro-organism from incisional biopsy, n (%) | |
| Monomicrobial | 102 (64) |
| Group A Streptococcus | 74 (72) |
| Other | 10 (10) |
| | 7 (7) |
| 3 (3) 2 (2) 1 (1) 5 (5) |
| Polymicrobial | 55 (34) |
| 18 (32) 3 (5) 7 (12) |
| Negative cultures | 3 (19) |
ASA American Society of Anesthesiologists; IQR Interquartile Range; NSTI Necrotizing Soft Tissue Infection; SD Standard Deviation; TBSA Total Body Surface Area
a2 cases missing. bAcinetobacter baumanii, Enterobacter cloacae, Neisseria meningitidis, Proteus vulgaris and Vibrio parahaemolyticus
Hemodynamic parameters and laboratory results prior to surgery in necrotizing soft tissue infection patients
| n | Mean ± SD or Median (IQR) | Reference values | |
|---|---|---|---|
| Hemodynamic parameters | |||
| Systolic blood pressure | 155 | 114 ± 24 | 90–120 mmHg |
| Diastolic blood pressure | 155 | 65 ± 17 | 60–80 mmHg |
| Mean arterial pressure | 155 | 81 ± 18 | 70–100 mmHg |
| Heart rate | 155 | 104 (88–120) | 60–100 beats/minute |
| Respiratory rate | 100 | 20 (15–25) | 12–20 breaths/minute |
| Temperature | 156 | 37.4 ± 1.1 | 36–38 °C |
| Blood test results | |||
| Hemoglobin | 94 46 | ♂ 8.0 ± 1.5 ♀ 7.2 ± 1.2 | ♂ 8.6–10.7 mmol/L ♀7.4–9.6 mmol/L |
| Hematocrit | 134 | 37 ± 7 | 41–50% |
| Platelet count | 118 | 183 (137–264) | 150–450 × 109/L |
| White blood cell count | 146 | 15.4 (10.2–20.5) | 0.8–4.0 × 109/L |
| Sodium | 130 | 135 ± 6 | 136–146 mmol/L |
| Potassium | 130 | 4.0 ± 0.6 | 3.8–5.0 mmol/L |
| Creatinine | 136 | 125 (78–184) | 64–104 μmol/L |
| Total bilirubin | 82 | 16 (9–28) | 3–21 mmol/L |
| Lactate | 65 | 3.5 (2.2–5.4) | 0.0–2.2 mmol/L |
| Lactate dehydrogenase | 85 | 235 (194–329) | 0–250 U/L |
| Creatine kinase | 61 | 389 (75–1333) | 0–170 U/L |
| C-reactive protein | 146 | 296 ± 142 | 0–10 mg/L |
| Glucose | 114 | 7.0 (5.9–8.4) | 3.6–5.6 mmol/L |
| Arterial blood gas resultsa | |||
| pH | 91 | 7.36 (7.28–7.44) | 7.37–7.45 |
| PaO2 | 81 | 89 (80–132) | 70–100 mmHg |
| PaCO2 | 81 | 33 (27–40) | 35–45 mmHg |
| Bicarbonate | 91 | 19 ± 5 | 22.0–28.0 mmol/L |
| Base excess | 91 | − 6.1 ± 5.8 | − 3.0–3.0 mmol/L |
| Risk scores | |||
| LRINEC score | 108 | 7 (6–9) | Range 0–13 |
| SOFA score | 54 | 5 ± 3 | Range 0–24 |
APACHE II score Septic upon admission, n (%) Septic prior to surgery, n (%) | 55 152 153 | 13 ± 6 47 (31) 50 (33) | Range 0–67 qSOFA < 2 and/or SOFA score < 2 qSOFA < 2 and/or SOFA score < 2 |
APACHE Acute Physiologic Assessment and Chronic Health Evaluation, IQR Interquartile Range, LRINEC Laboratory Risk Indicator for Necrotizing fasciitis, qSOFA Quick Sequential Organ Failure Assessment, SD Standard Deviation, SOFA Sequential Organ Failure Assessment
aIf only a venous blood gas was available, only pH, bicarbonate and base deficit were extracted
Factors associated with mortality in necrotizing soft tissue infection patients who are able to undergo surgery
| Survived | Deceased | ||
|---|---|---|---|
| ASA classification, n (%) | 0.057 | ||
| I–II | 89 (91) | 9 (9) | |
| III–IV | 49 (79) | 13 (21) | |
| Location of the NSTI, n (%) | |||
| Extremities | 78 (86) | 13 (14) | 0.464 |
| Trunk | 13 (81) | 3 (19) | 1.000 |
| Perineum | 39 (89) | 5 (11) | 0.798 |
| Total body area affecteda, median (IQR) | 3 (2–5) | 7 (3–10) | |
| Monomicrobial NSTIb, n (%) | 86 (84) | 16 (16) | 0.478 |
| Polymicrobial NSTIb, n (%) | 49 (89) | 6 (11) | 0.478 |
| SOFA score prior to surgeryc, median (IQR) | 5 (2–7) | 6 (6–9) | 0.146 |
| APACHE II score prior to surgeryd, median (IQR) | 11 (9–15) | 13 (13–17) | |
| Time from presentation to surgery, median (IQR) | 2 (0–3) | 1 (0–3) | 0.567 |
| Septic prior to surgery, n (%) | 39 (78) | 11 (22) | |
| Initial operative timee, median (IQR) | 57 (31–89) | 62 (45–90) | 0.355 |
P-values in bold denote significant values
APACHE Acute Physiologic Assessment and Chronic Health Evaluation, IQR Interquartile Range, LRINEC Laboratory Risk Indicator for Necrotizing fasciitis, qSOFA Quick Sequential Organ Failure Assessment, SD Standard Deviation, SOFA Sequential Organ Failure Assessment
a2 missing cases; b3 missing cases; c106 missing cases; d105 missing cases; e1 missing case
Fig. 2Histogram of distribution of operative times of initial surgery for necrotizing soft tissue infections
Treatment characteristics and outcomes of necrotizing soft tissue infection patients undergoing surgery
| Surgical treatment | |
| Time from surgical consult to surgery in hoursa, median (IQR) | 7 (4–31) |
| Operative time of initial surgery in minutesa, median (IQR) | 59 (35–90) |
| Time in operating room for initial surgery in minutesb, median (IQR) | 90 (64–121) |
| Amputation performed, n (%) | 21 (13)c |
| Amputation during initial surgery | 13 (62) |
| Skin sparing operating technique utilized, n (%) | 33 (21) |
| Intra-operative assessed frozen section and/or Gram stain, n (%) | 36 (23) |
| Frozen section, n (%) | 22 (14) |
| Gram stain, n (%) | 24 (15) |
| Number of surgeries for NSTI within first 30 daysd, median (IQR) | 3 (2–5) |
| Days from initial surgery to definitive wound closure in daysd, median (IQR) | 25 (10–56) |
| Postoperative phase | |
| Admitted to ICU, n (%) | 110 (67) |
| Length of ICU stay in dayse, median (IQR) | 4 (2–10) |
| Length of hospital stay in daysd, median (IQR) | 24 (15–42) |
| Major infectious complication during hospital course, n (%) | |
| Sepsis | 88 (55) |
| Multiple organ dysfunction syndrome | 14 (9) |
| Deceased within 30 days after presentation, n (%) | 22 (14) |
| Days from initial surgery to death in days, median (IQR) | 2 (1–6) |
| Cause of death, n (%) | |
| Sepsis | 11 (50) |
| Withdrawal of care | 10 (45) |
| Complication | 1 (5) |
ICU Intensive Care Unit, IQR Interquartile Range, NSTI Necrotizing Soft Tissue Infection
a1 case missing; b36 cases missing; cOf which 11 were lower extremity amputation, 7 (hemi)scrotectomies, 2 orchidectomies, 1 bilateral mastectomy; dOnly patients who survived hospital stay; eOnly patients who survived ICU stay
Factors associated with prolonged operative time for patients with necrotizing soft tissue infections
| Operative time in minutes, | Operative time in minutes, | ||
|---|---|---|---|
| if yes | if no | ||
| median (IQR) | median (IQR) | ||
| Location of NSTI | 0.158a | ||
| Head/neck | 76 (55–104) | 57 (31–90) | 0.147 |
| Trunk | 90 (59–110) | 55 (31–76) | |
| Perineum | 49 (36–68) | 60 (31–90) | 0.474 |
| Upper extremity | 45 (19–90) | 60 (37–90) | 0.368 |
| Lower extremity | 59 (35–76) | 59 (34–90) | 0.650 |
| Estimated TBSA affected | |||
| < 2% | 38 (26–65) | 60 (37–90) | 0.089 |
| 2–3% | 45 (22–63) | 65 (38–96) | |
| 4–5% | 72 (38–100) | 56 (30–76) | 0.134 |
| > 6% | 71 (43–100) | 47 (29–75) | |
| Monomicrobial NSTI infection | 59 (30—90) | 60 (39—75) | 0.711 |
| Amputation during initial surgery | 59 (43–93) | 59 (35–89) | 0.584 |
| Skin sparing operating technique utilized | 46 (30–90) | 60 (36–89) | 0.715 |
| Intra-operative assessed frozen section and/or Gram stain | 87 (63–106) | 46 (29–73) |
P-values in bold denote significant values
IQR Interquartile range, NSTI Necrotizing Soft Tissue Infection, TBSA Total Body Surface Area
aKruskal Wallis test; bChi-squared for trend
Association of operative time per 20 min on various outcomes of necrotizing soft tissue infections
| β coefficient | Standard error | ||
|---|---|---|---|
| Mortality (n = 150) | |||
| Operative time (per 20 min) | 0.14 (− 0.06 to 0.33) | 0.10 | 0.170 |
| | |||
| | |||
| | |||
| Amputation required after initial surgery (n = 150) | |||
| Operative time (per 20 min) | 0.11 (− 0.012 to 0.35) | 0.12 | 0.356 |
| | |||
| | |||
| | |||
| Length of ICU stay (n = 104) | |||
| Operative time (per 20 min) | 1.43 (0.46 to 2.40) | 0.49 | |
| | |||
| | | ||
| | − | ||
| Length of hospital stay (n = 129) | |||
| Operative time (per 20 min) | 3.25 (0.23 to 6.27) | 1.53 | |
| | | ||
| | |||
| | |||
| Number of surgeries within first 30 days (n = 145) | |||
| Operative time (per 20 min) | 0.01 (− 0.14 to 0.16) | 0.08 | 0.873 |
| | | ||
| | − | ||
| | − | ||
| Days until definitive wound closure (n = 120) | |||
| Operative time (per 20 min) | − 2.77 (− 7.64 to 2.09) | 2.46 | 0.262 |
| | − 2.52 (− 6.01 to 0.96) | 1.76 | 0.154 |
| | 8.32 (− 14.40 to 31.05) | 11.47 | 0.470 |
| | 11.41 (− 1.27 to 24.09) | 6.40 | |
Bold values denote significant values
ASA = American Society of Anesthesiologists; ICU = Intensive Care Unit